SCHEMBL17599551

SCHEMBL17599551

CCOC(=O)C1=C(c2cc(NS(=O)(=O)c3c(C)c(C)cc(C)c3C)c3ccccc3c2)CCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 4/20 0.43
▸ SLC6A3 Q01959 3/20 0.43
▸ KMT2A Q03164 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CRHBP P24387 1/20 0.41
▸ CRHR2 Q13324 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ CNR2 P34972 2/20 0.41
▸ SLC6A4 P31645 1/20 0.41
▸ KEAP1 Q14145 3/20 0.38
▸ TLR2 O60603 3/20 0.38
▸ LMNA P02545 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ NFE2L2 Q16236 1/20 0.38
▸ TP53 P04637 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ CDC25B P30305 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599527 0.90 SLC6A3 (0.53) SLC6A2SLC6A3KMT2AKDM4EMEN1
SCHEMBL17599453 0.85 KEAP1 (0.46) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17614083 0.76 KEAP1 (0.41) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599550 0.76 KEAP1 (0.41) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599499 0.74 KEAP1 (0.48) SLC6A2SLC6A3KMT2AKDM4EMEN1
SCHEMBL17599467 0.72 KMT2A (0.55) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599470 0.71 MEN1 (0.46) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599510 0.71 KMT2A (0.53) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599548 0.70 NPSR1 (0.53) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17614106 0.70 KEAP1 (0.50) KMT2AKDM4EMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP claimed
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback